Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial

NCT: NCT04811235 · TERMINATED

NCT IDNCT04811235
StatusTERMINATED
Start Date2022-09-24
Completion2026-04-01
SponsorUniversity of British Columbia (OTHER)
First posted
Last updated

Brief Summary

The study involves the 'first-in-human' evaluation of a novel optical sensor which uses near-infrared spectroscopy (NIRS) technology to assess oxygenation and hemodynamics of the injured spinal cord. The NIRS sensor is laid on top of the dura, at the site of the SCI, and emits near-infrared light signals into the cord to measure tissue oxygenation and tissue hemodynamics in real-time. Our testing of this novel NIRS sensor in patients with acute SCI represents the first step in translating this technology for human use.

Frequently Asked Questions

What is Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial?

Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial is a clinical trial registered under NCT04811235. Current status: TERMINATED.

What is the status of NCT04811235?

The current status of NCT04811235 (Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial) is: TERMINATED.

When did Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial start?

Optical Monitoring With Near-Infrared Spectroscopy for Spinal Cord Injury Trial started on 2022-09-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.